Retatrutide, Lilly's next-gen triple agonist, delivered weight loss up to 71.2 lbs with osteoarthritis pain relief in prior trials
The most pronounced differences were observed across gastrointestinal and metabolic events, including nausea (9,651 vs 38,030), vomiting (4,383 vs 17,062), pancreatitis (1,389 vs 6,655), and hypoglycaemia (773 vs 1,778), all substantially lower with combination therapy (Table 1)
At the higher 1.8 mg daily dose, it lasts about 39 days (roughly five and a half weeks)
Luke Laffin about his recent study looking at statins versus various supplements touted as cholesterol-lowering
The PSP compound exerts antidepressant-like behavior by modulating the MGBA axis
(adapted) Jastreboff AM, et al